2009

Дек
26

Подпишись на RSS-трансляцию статей.

Для того чтобы вовремя узнавать о новых статьях и публикациях в моем журнале, вы можете подписаться на RSS-трансляцию и всегда быть в курсе обновлений, при этом значительно сэкономив время. Что такое RSS и как его использовать, читайте далее…
Jxnj.1 Подпишись на RSS трансляцию статей.

Автор nyse    Рубрики Блог
2009

Апр
15

Торговая стратегия торговли на NYSE,NASDAQ,AMEX (Черновик, постоянно буду дописывать)

В процессе редактирования 21.10.2010 Суть моей торговой стратегии проста,  это торговля на продолжение тренда или разворот акции внутри дня после значительного роста или падения.

Основные сигналы на продолжение тренда:

  • На дневном графике акция должна расти или пройти  ключевой уровень. Чаще всего торгую акции которые находятся на годовом хае или прошли какой то значимый уровень за 100 дней.
  • Смотрю уровни на дневном и 15 минутном масштабе, там должен быть виден четкий тренд
Автор admin    Рубрики Стратегия
2014

Авг
15

Робот в день завала

Повезло сегодня роботу, пока о нем ничего подробно писать не буду. Торгует на реальном счете, через Sterling на фондовом рынке США (NYSE, NASDAQ, AMEX). Пока только тестовые испытания по 100 акций.

Закрыл на первом движении падения рынка.

 3400 акций проторговал +500Gross

4cb65463ba73169dd5f2e059a51366d0 Робот в день завала

 

SPY за сегодня:

Автор nyse    Рубрики Торговый робот
2014

Авг
15

Spy растет на премаркете

Ближайший уровень поддержки по SPY – 196.00 уровень сопротивления – 196.50

 analytics 15 08 2014 Spy растет на премаркете

AMGN смотрим на откат вниз

WHR продажа от 150

MHK покупка выше 140

MIDD покупка выше 88

HAR покупка выше 113

SVXY покупка выше 84

GILD смотрим на продажу, ГЭП на премаркете

TAP покупка выше 75

 

Gapping up/down: JCP +2% after earnings, MNST +20% on KO strategic partnership, ACHN +17% after Phase 2 data; JD and JWN -4% after earnings; ICPT -2% after initiation with Underperf

Gapping up
In reaction to strong earnings/guidance: DQ +10.8%, VRML +10.7%, RIOM +9.5%, CEP +7.9%, LIME +7.6%, YOD +7.5%, SKBI +5.6%, WYY +5.4%, SINA +5.2%, ADSK +4.4%, HTM +4.3%, AMAT +3.8%, XON +3.6%, AGRX +2.7%, ROX +2.7%, CHL +2.7%, UPIP +2.5%, LEI +2%, JCP +2%, KITE +1.7%, MNDL +1.4%, AEG +1.2%, SAND +1%, EL +0.8%, A +0.7%.

M&A news: MNST +20.3% (Monster Beverage and Coca-Cola enter into long-term strategic partnership), KO +1.8% (Monster Beverage and Coca-Cola enter into long-term strategic partnership).

Other news: ACHN +17.5% (achieves 100% sustained virologic response rate from an eight week Phase 2 trial evaluating a ribavirin-free regimen of ACH-3102 and Sofosbuvir for Genotype 1 HCV), CRMD +8.2% (FDA accepted co’s pivotal Phase 3 study protocol), FRO +4.3% (cont strength), SODA +3.7% (following MNST / KO ), GCI +2.3% (Icahn disclosed 6.63% active stake in 13D filing; supports split of the company), BHP +2.2% (announced update on portfolio; demerger of a selection of assets is co’s preferred option), GLF +2% (to replace QCOR in the S&P SmallCap 600), DNOW +1.9% (new Berkshire Hathaway stake), PARR +1.9% (announced successful completion of common stock rights offering and award of $164 mln contract with Defense Logistics Agency Energy), MNK +1.9% (completes acquisition of Questcor (QCOR)), GILD +1.5% (disclosed favorable ruling in Roche (RHHBY) / Pharmasset case), CHTR +1% (new Berkshire Hathaway stake), EBAY +0.5% (may soon accept bitcoins at its payment unit, according to reports).

Analyst comments: CHL +2.7% (upgraded to Neutral from Underperform at Mizuho), UPL +1.8% (upgraded to Buy from Neutral at UBS ), GSJK +1.5% (upgraded to Overweight from Neutral at JP Morgan), MBI +1.2% (upgraded to Buy from Neutral at BTIG Research ), NXPI +0.8% (initiated with a Buy at Stifel)

Gapping down
In reaction to disappointing earnings/guidance: ICLD -9%, OPXA -7.8%, PIH -5.7%, PCTY -4.6%, JD -4.4%, JWN -4%, XGTI -3.9%, WB -3.1%, EXTR -1.9%.

Other news: NQ -15.8% ( announces management changes; CFO has resigned from his position for family reasons effective Aug 22, 2014), IDCC -6.7% (co announced it is disappointed with decision by the U.S. International Trade Commission to terminate Investigation No. 337-TA-868), NWBO -5.1% (announced pricing of $17.5 mln offering of convertible notes; convertible at $7.30/share; will fund new manufacturing capacity in Europe), CNAT -3.3% ( filed for a $150 mln mixed securities shelf offering), NEO -2.7% (announced public offering of common stock; size not disclosed), MASI -1.7% (disclosed it received a warning letter from the U.S. FDA regarding compliance with current Good Manufacturing Practices at Masimo’s Irvine, CA manufacturing facility.), ZGNX -1.5% (disclosed it received a paragraph IV certification from Actavis (ACT) advising of the filing of an ANDA for a generic version of Zohydro).

Analyst comments: ICPT -2.1% (initiated with a Underperform at FBR Capital; tgt $172 ), KKR -1% (downgraded to Market Perform from Outperform at Wells Fargo), BEBE -0.7% (downgraded to Neutral from Buy at Janney).

 

Автор GT_support    Рубрики Торговые идеи
2014

Авг
14

SPY на уровне вчерашнего закрытия

Ближайший уровень поддержки по SPY – 194.85 уровень сопротивления – 195.40

 analytics 14 08 2014 SPY на уровне вчерашнего закрытия

ITMN продажа ниже 50

CSIQ продажа от 31

YELP продажа ниже 74

SEAS покупка выще 19

HGR покупка выше 22.50

Gapping up/down: PLUG +7%, PRGO +4% and KSS +2% after earnings; IOC +2% on M&A spec, TSLA +1% after initiation at CS; NDLS -22% and CSCO -1.5% after earnings, SEAS -1% after muliple dg’s

Gapping up
In reaction to strong earnings/guidance: PLUG +7%, PRGO +4.2%, AZPN +4.1%, DL +3.5%, NTES +3%, IAG +2.6%, RRGB +2.2%, CASI +2.2%, KSS +1.9%, NTAP +1.8%, RMAX +1.4%, ELP +0.9%, FRSH +0.7%, MTLS +0.5%, SAND +0.5%.

M&A news: IOC +2% (Hearing Bernstein suggesting Exxon (XOM), Total (TOT) and Woodside (WOPEY) as potential InterOil bidders).

Select financial related names showing strength: IRE +2.3%, CS +1.8%, HSBC +1.7%, RBS +1.2%.

Select battery related stocks trading higher after PLUG earnings: FCEL +2.5%, BLDP +2.3%, ZBB +1.4%.

Other news: SUPN +6.5% (receives FDA fast track designation for SPN-810), TCK +3% (still checking), GSL +2.3% (announced pricing of depositary shares representing $35 mln of preferred stock at $25 per share), IQNT +1.9% (increased quarterly dividend 100% to $0.15 from $0.075 per share), PANW +1.9% (cont momentum), PRSC +1.7% (to replace UNS Energy in the S&P SmallCap 600), RSX +1.4% (Pres Putin reportedly will do utmost to end conflict; Interfax reports the Russian govt will adjust list of banned food imports by 8/15), WY +1.4% (increases dividend by 32% and announces $700 mln share repurchase program), TPH +1.3% (positive mention on Mad Money), ZOES +1.1% (upsizes offering by 500K shares and prices 4.5 mln shares of common stock at $30.25), Q +1.1% (positive mention on Mad Money), PCP +1% (Board approved a $1 bln expansion to co’s existing share repurchase program).

Analyst comments: ARUN +3% (upgraded to Buy form Hold at Stifel), TSLA +1.3% (initiated with a Outperform at Credit Suisse)

Gapping down
In reaction to disappointing earnings/guidance: NDLS -22.6%, CNAT -11.8%, VCYT -11.6%, TKMR -11.3%, (also — co remains on clinical hold as it relates to the multiple-ascending dose portion of the Phase I clinical study in healthy volunteers with TKM-Ebola, expects matter to be resolved by Q4 2014; co also reported earnings), XONE -9.9%, YUME -9.1%, DGLY -8.7%, VJET -8.2%, OCLR -5.8%, VIPS -3.5%, DANG -3.5%, EXXI -3.3%, AEG -2.4%, CSCO -1.5%, SLW -1.2%, CIG -1.2%.

M&A news: NRG -1% (reaches agreement to acquire Goal Zero; financial terms not disclosed).

Select metals/mining stocks trading lower: RIO -2% ACH -1.9%, SLW -1.2%, CLF -0.9%, BHP -0.7%.

Other news: CNAT -11.8% (co said it is deferring the announcement of top-line results from the Phase 2 NAFLD/NASH clinical trial to Q1 2015; co also reported earnings), FSFR -8% (announced public offering of 22.8 mln shares of common stock), ENPH -5.6% (announced proposed public offering of common stock by selling stockholders), PDII -3.5%  (co’s subsidiary Interpace Diagnostics entered the molecular diagnostics market with thyroid and pancreatic cancer test portfolio acquisition of miRInform for $8 mln in upfront cash, future commercial milestone-based payments, and royalties), AMH -3.2% (announced public offering of 13 mln shares of Class A common shares), AMGN -2.2% (announced that the Phase 3 clinical trial FOCUS evaluating Kyprolis in patients with relapsed and advanced refractory multiple myeloma did not meet its primary endpoint), TKR -1.9% (announced proposed offering of $300 mln in senior notes due 2024).

Analyst comments: RMTI -4.2% (initiated with a Underperform at FBR Capital), ITMN -3% (downgraded to Neutral from Buy at Goldman), MSG -1.3% (downgraded to Hold at Topeka Capital Markets), SEAS -1.1% (downgraded to Market Perform from Outperform at Wells Fargo, downgraded to Neutral from Buy at BofA/Merrill), FCX -0.9% (downgraded to Hold from Buy at Stifel).

 

Автор GT_support    Рубрики Торговые идеи
2014

Авг
13

ALIBABA БРОСАЕТ ВЫЗОВ БАНКИРАМ: КОМУ ДОСТАНУТСЯ ДЕНЬГИ ОТ IPO?

alibaba 1 ALIBABA БРОСАЕТ ВЫЗОВ БАНКИРАМ: КОМУ ДОСТАНУТСЯ ДЕНЬГИ ОТ IPO?

Банкиры в ступоре: кому достанется больше денег от продажи акций компании Alibaba? Дело в том, что китайская компания зарегистрирована на Каймановых островах, а листинг проводить будет на рынках США.

Уже давно все СМИ трубят о том, что IPO Alibaba Group Holding должен стать крупнейшим в истории, а сейчас банкиры самопроизвольно создают себе большие проблемы: как им сохранить акции, как только они начнут торговать?

В то время, как все крупные IPO проводились жестко и четко, в публичном размещении акций компании электронной коммерции возникают некоторые специфические препятствия.

Автор nyse    Рубрики Статьи
2014

Авг
11

Миллиард долларов за один день

fbb9bbdeeccc8af6f5b9479ed30cdbae Миллиард долларов за один день

Adage Capital Management, бостонский хедж-фонд, запущенный двумя бывшими управляющими эндаумента Гарвардского университета, заработал почти 1 млрд долларов за один день на акциях биотехнической компании после успешного прохождения испытания нового препарата.

Автор nyse    Рубрики Статьи
2014

Авг
11

Интервью экс-трейдера Антона Крейла J.P. Morgan, Goldman Sachs и Lehman Brothers

Итак, нам повезло видеть в студии Антона Крейла

Он начал торговать в 16 лет на свои деньги

Затем его купили Goldman Sachs, также за ним охотились Lehman Brothers, JP Morgan, пока он не ушел от дел

начал путешествовать по миру

Автор nyse    Рубрики Видео
2014

Авг
8

Исследование ноотропов или разгоняем мозг

587a8f Исследование ноотропов или разгоняем мозг

Исследование ноотропов или разгоняем мозг

Являясь подписчиком Хабра очень люблю читать статьи в хабе GTD и о том как люди пытаются справляться с возникающими в их жизни трудностями организации жизнедеятельности и оптимизации жизненных процессов. Кто-то даже пишет об успешных приемах, придуманных ими или почерпнутых из разных источников. В большинстве же, мне кажется, подобные статьи пишутся на волне восторга от получаемых результатов от новой методики, но со временем волна спадает и приходится искать новые варианты.

Сам я, так же как и многие другие люди, подвержен подобным волновым процессам. Но в своей жизни я заметил одно явление в организме человека, выражающееся в том, что большинство негативных эффектов жизнедеятельности, будь то прокрастинация, апатия, депрессия и пр., возникают на фоне нарушений внутри мозговых процессов. Такие нарушения могут быть спровоцированы различными причинами — от физической травмы головы с сотрясением мозга (как в моем случае) до негативного воздействия окружающей среды.

Все эти нарушения могут протекать в мало выраженной форме и человек, думая, что он здоров и ему просто не хватает времени для сна, продолжает находиться в таком пагубном состоянии не подозревая об этом. Смею предположить, что такое состояние характерно для большинства людей. А в результате, из-за гипоксического (кислородная недостаточность) состояния мозга человек продолжает жить в нем, не задумываясь о существовании лучшей жизни icon smile Исследование ноотропов или разгоняем мозг

Какое-то время назад, я пришел к выводу, что нашему мозгу нужен постоянный «прикорм» в виде ноотропов — препаратов, оказывающих прямое активирующее влияние на работу мозга и препаратов улучшающих мозговое кровообращение и тем самым усиливающих стойкость мозга к гипоксическим состояниям. Отдельно стоит отметить существование адаптогенов — препаратов природного или искусственного происхождения, способных повышать сопротивляемость организма в целом и мозга в частности к вредным воздействиям окружающей среды. К таким, испробованным мной, относятся Женьшень, Родиола розовая, продукты пчелиного происхождения. К слову, нааиболее понравилась настойка Родиолы розовой. Но в этой статье речь о них не пойдет.

Автор nyse    Рубрики Статьи
2014

Авг
8

SPY отыграл гэп вниз на премаркете

Ближайший уровень поддержки по SPY – 189.75 уровень сопротивления – 191.75

 analytics 08 08 2014 SPY отыграл гэп вниз на премаркете

DRC смотрим на продажу

CXO продажа ниже 131

AGN покупка выше 152

SNI покупка выше 77.50

WLP покупка выше 107.50

CI мотрим на продолжение падение

Gapping up
In reaction to strong earnings/guidance: MELI +14.7%, SHOR +14.5%, ANET +12.2%, AGO +9.2%, BNFT +6.8%, GST +6.6%, MDVN +6.3%, AIRM +5.6%, AL +5.6%, GHDX +5.4%, NOG +4.8%, MHR +4.8%, GPS +4.7%, UBNT +4.6%, NVDA +4.5%, BAGR +4.4%, ELX +4.1%, UEIC +3.8%, AMRN +3.6%, DAR +3.5%, SPPI +2.9%, SCTY +2.8%, VVUS +2.6%, TUMI +2.4%, ZIOP +2.3%, CLNE +1.7%, PGNX +1.7%, CBS +1.4%, MNST +1.4%, WIFI +1%, BIOL +0.9%.

M&A news: TI +4.1% (in discussions with Vivendi (VIVHY)’s GVT regarding merger, according to reports).

Select financial related names showing strength: RBS +3.2%, SAN +2%, UBS +1.7%, DB +1.5%, CS +1.1%, BCS +1%.

Select metals/mining stocks trading higher: SSRI +1.3%, VALE +1.2%, AUY +0.8%, IAG +0.8%, GG +0.6%, GDX +0.4%.

Other news: TKMR +14.9% (FDA Modifies co’s TKM-Ebola Clinical Hold to Partial Hold), LULU +5% (confirms lululemon founder Chip Wilson and Advent International announce stock sale and support agreements; will sell ~13.85% of the co’s outstanding shares, for ~$845 mln), HZNP +2.7% (Visium Asset Management discloses 5.5% passive stake in 13G filing), FRGI +2.6% (positive mention on Mad Money), MCRL +2.4% (Starboard disclosed 12.0% active stake in 13D filing), JCP +2.2% (positive Mad Money mention), LJPC +1.9% (Tang Capital disclosed 11.4% active stake in 13D filing), PLUG +1.4% (still checking).

Analyst comments: BCRX +4.6% (initiated with a Overweight at JP Morgan), NMBL +1.5% (initiated with a Outperform at Wells Fargo), MNST +1.4% (upgraded to Neutral from Sell at Longbow), ABX +1.3% (added to Conviction Buy list at Goldman), ATVI +0.7% (upgraded to Buy from Neutral at Longbow), EAT +0.5% (upgraded to Outperform from Mkt Perform at Raymond James)

Автор GT_support    Рубрики Торговые идеи
2014

Авг
7

SPY поднимается на премаркете

Ближайший уровень поддержки по SPY – 192.25 уровень сопротивления – 193.00

 analytics 07 08 2014 SPY поднимается на премаркете

WAG смотрим на рост

PRGO выше 143 покупка

OAS ниже 47 продажа

Gapping up/down: SSYS +12%, MIDD +7%, and SUNE +5% after earnings, select solar names trading higher, LIME +200% after contract win; ATML -5% and COST -1% after earnings/SSS, select metals/miners trading lower
Gapping up
In reaction to strong earnings/guidance/SSS: SAAS +18.5%, LGP +18.4%, SSYS +12.4%, JACK +11.2%, HZNP +11%, MCP +10.8%, GDP +9.4%, TRMR +8.7%, MBI +7%, MIDD +6.7%, FOXA +5.2%, HAR +5.1%, TPH +4.8%, SUNE +4.8%, DXCM +4.7%, HIMX +4.6%, PKT +4.5%, LDRH +4.5%, EVHC +4.3%, ATHM +4.3%, CRIS +4.2%, QIWI +4.1%, DEG +3.8%, WTI +3.7%, BREW +3.5%, TROX +3.5%, EVRY +3.5%, TDC +3.4%, WWAV +3.3%, KERX +3.2%, DEPO +3.1%, MUSA +2.9%, CTL +2.9%, VNDA +2.9%, WEN +2.8%, JBT +2.6%, OFIX +2.5%, AFSI +2.5%, EXAR +2.4%, RIG +2.3%, RDN +2.3%, PACD +2.2%, DYN +2.2%, ZFGN +2.2%, AGU +2.1%, CSII +2%, ICE +2%, BKD +1.8%, TWO +1.8%, NLY +1.7%, TCAP +1.7%, AAON +1.6%, CDXS +1.5%, WR +1.5%, DNB +1.3%, TEG +1.3%, PMT +1.3%, RIO +1.3%, MRIN +1.2%, RGLD +1.2%, DUK +1.2%, ITMN +1.1%, ETP +1.1%, SN +1.1%, SYMC +1.1%, MNK +1.1%.

M&A news: CST +6.6% (CST Brands (CST) to acquire the general partner of LGP for $17 mln in cash and ~ 2.044 mln shares of CST common stock; CST authorizes repurchase of up to $200 mln of common stock ), NEM +0.8% (exec says company still open to merger with Barrick Gold (ABX), according to reports).

Select solar names showing strength: HSOL +2.9%, JASO +2.4%, TAN +2.4%, TSL +1.8%, CSIQ +1.7%, JKS +1.4%, YGE +1.2%, FSLR +0.7%.

Other news: LIME +203.8% (announced utility program contract win valued at $180 mln), OGXI +23.3% (announces appointment of John Bencich as VP and CFO), LGP +18.4% (CST Brands (CST) to acquire the general partner of LGP for $17 mln in cash and ~ 2.044 mln shares of CST common stock; CST authorizes repurchase of up to $200 mln of common stock ), MCP +10.8% (announces commitment for a $400 mln financing arrangement ), MDCO +10.6% (received FDA approval of Orbactiv (oritavancin) for the treatment of skin infections), CTRP +10% (co and Priceline Group (PCLN) expand partnership; Priceline to make $500 mln investment in Ctrip), GTXI +7.8% (filed for a ~22.156 mln share common stock shelf offering which includes ~10.18 mln shares of its common stock issuable upon the exercise of outstanding warrants, which are held by the selling stockholders), VJET +6.2% (following SSYS results), CTIC +6.1% (receives FDA Fast Track Designation for Pacritinib, a novel JAK2 Inhibitor for the treatment of myelofibrosis), XONE +5.9% (following SSYS results), PERY +4.9% (following late move higher on volume — attributed to M&A speculation), DDD +3.4% (following SSYS results), WBAI +2.1% (enters into strategic partnership with China Mobile Limited (CHL)), DB +2% (peer Commerzbank trading higher after results), VMW +1.7% (announced authorization of stock repurchase program of up to $1 bln of its Class A common stock), BKS +1.5% (Google and Barnes & Noble (BKS) want to compete with Amazon (AMZN) on speedy book delivery, according to reports), MNK +1.1% (announced settlement of OFIRMEV (acetaminophen) injection patent litigation with Fresenius Kabi USA), BAC +0.9% (reports suggesting $16.5 bln DoJ settlement).

Analyst comments: AOL +3.3% (upgraded to Buy from Hold at Cantor Fitzgerald), CCL +2.1% (upgraded to Buy from Neutral at BofA/Merrill), ANR +1.6% (upgraded to Neutral from Sell at UBS), ARMH +1.3% (upgraded to Buy from Hold at The Benchmark Company), WAG +1% (upgraded to Hold from Sell at Cantor Fitzgerald)

Gapping down
In reaction to disappointing earnings/guidance/SSS: THOR -26.4%, ELON -17%, BWC -12.6%, GEOS -9.5%, RNDY -9.5%, ANAD -9.1%, IO -8.4%, CSOD -8.2%, COUP -7.6%, TXTR -6.6%, OSUR -6%, TNGO -5.4%, ATML -5.2%, ATRS -5.2%, FTK -5.1%, ZEUS -4.9%, PHMD -4.7%, ERII -4.6%, CLDX -4.5%, ZU -4.5%, SD -4.5%, NVAX -4.1%, GPOR -3.9%, IXYS -3.9%, DVAX -3.9%, DRTX -3.7%, WIN -3.5%, CPA -3.3%, EVC -3.2%, NIHD -3.2%, BDBD -3%, CECE -3%, LAMR -3%, RDUS -2.8%, SABR -2.8%, IDCC -2.7%, FRED -2.6%, ACAS -2.4%, GMCR -2.2%, TSE -2.2%, SRPT -2%, MWE -1.9%, DSCI -1.9%, AUXL -1.8%, HIL -1.6%, MYL -1.6%, HRC -1.6%, YY -1.5%, CXW -1.5%, PRSC -1.5%, TOPS -1.5%, AGYS -1.4%, CPE -1.3%, LPI -1.3%, PHX -1.3%, CGI -1.1%, NVTL -1.1%, CTB -1%, MPEL -1%, COST -1%.

Select metals/mining stocks trading lower: TC -2.2%, AU -1.5%, AU -1.5%, HL -1.2%, HL -1.2%, IAG -1.1%, HMY -1%, BHP -0.5%, MT -0.4%.

Other news: NYMX -8% (Paul Averback sold in a private transaction for financial planning purposes 470,600 common shares of NYMX for a total consideration of $2.4 mln), UMPQ -3.5% (announces secondary offering of 15 mln shares held by Thomas H. Lee Partners and Warburg Pincus), SHPG -1.8% (still checking), PT -1.5% (still checking), YY -1.5% (Shanghai -1.3% overnight), EBS -1.3% (submits Biologics license application to FDA for Anthrax Immune Globulin Intravenous), ASTM -0.9% (filed for a $20 mln common stock offering), RSPP -0.8% (announces pricing of 10 mln shares of common stock offering at $25.65/share).

Analyst comments: NUS -0.6% (downgraded to Neutral from Overweight at JP Morgan), AET -0.6% (downgraded to Neutral from Buy at Goldman), UNH -0.6% (removed from Conviction Buy list at Goldman), PERI -0.5% (downgraded to Hold from Buy at Needham), VOD -0.4% (downgraded to Mkt Perform from Outperform at Raymond James).

Автор GT_support    Рубрики Торговые идеи
2014

Авг
7

SPY поднимается на премаркете

Ближайший уровень поддержки по SPY – 192.25 уровень сопротивления – 193.00

 analytics 07 08 2014 SPY поднимается на премаркете

WAG смотрим на рост

PRGO выше 143 покупка

OAS ниже 47 продажа

Gapping up/down: SSYS +12%, MIDD +7%, and SUNE +5% after earnings, select solar names trading higher, LIME +200% after contract win; ATML -5% and COST -1% after earnings/SSS, select metals/miners trading lower
Gapping up
In reaction to strong earnings/guidance/SSS: SAAS +18.5%, LGP +18.4%, SSYS +12.4%, JACK +11.2%, HZNP +11%, MCP +10.8%, GDP +9.4%, TRMR +8.7%, MBI +7%, MIDD +6.7%, FOXA +5.2%, HAR +5.1%, TPH +4.8%, SUNE +4.8%, DXCM +4.7%, HIMX +4.6%, PKT +4.5%, LDRH +4.5%, EVHC +4.3%, ATHM +4.3%, CRIS +4.2%, QIWI +4.1%, DEG +3.8%, WTI +3.7%, BREW +3.5%, TROX +3.5%, EVRY +3.5%, TDC +3.4%, WWAV +3.3%, KERX +3.2%, DEPO +3.1%, MUSA +2.9%, CTL +2.9%, VNDA +2.9%, WEN +2.8%, JBT +2.6%, OFIX +2.5%, AFSI +2.5%, EXAR +2.4%, RIG +2.3%, RDN +2.3%, PACD +2.2%, DYN +2.2%, ZFGN +2.2%, AGU +2.1%, CSII +2%, ICE +2%, BKD +1.8%, TWO +1.8%, NLY +1.7%, TCAP +1.7%, AAON +1.6%, CDXS +1.5%, WR +1.5%, DNB +1.3%, TEG +1.3%, PMT +1.3%, RIO +1.3%, MRIN +1.2%, RGLD +1.2%, DUK +1.2%, ITMN +1.1%, ETP +1.1%, SN +1.1%, SYMC +1.1%, MNK +1.1%.

M&A news: CST +6.6% (CST Brands (CST) to acquire the general partner of LGP for $17 mln in cash and ~ 2.044 mln shares of CST common stock; CST authorizes repurchase of up to $200 mln of common stock ), NEM +0.8% (exec says company still open to merger with Barrick Gold (ABX), according to reports).

Select solar names showing strength: HSOL +2.9%, JASO +2.4%, TAN +2.4%, TSL +1.8%, CSIQ +1.7%, JKS +1.4%, YGE +1.2%, FSLR +0.7%.

Other news: LIME +203.8% (announced utility program contract win valued at $180 mln), OGXI +23.3% (announces appointment of John Bencich as VP and CFO), LGP +18.4% (CST Brands (CST) to acquire the general partner of LGP for $17 mln in cash and ~ 2.044 mln shares of CST common stock; CST authorizes repurchase of up to $200 mln of common stock ), MCP +10.8% (announces commitment for a $400 mln financing arrangement ), MDCO +10.6% (received FDA approval of Orbactiv (oritavancin) for the treatment of skin infections), CTRP +10% (co and Priceline Group (PCLN) expand partnership; Priceline to make $500 mln investment in Ctrip), GTXI +7.8% (filed for a ~22.156 mln share common stock shelf offering which includes ~10.18 mln shares of its common stock issuable upon the exercise of outstanding warrants, which are held by the selling stockholders), VJET +6.2% (following SSYS results), CTIC +6.1% (receives FDA Fast Track Designation for Pacritinib, a novel JAK2 Inhibitor for the treatment of myelofibrosis), XONE +5.9% (following SSYS results), PERY +4.9% (following late move higher on volume — attributed to M&A speculation), DDD +3.4% (following SSYS results), WBAI +2.1% (enters into strategic partnership with China Mobile Limited (CHL)), DB +2% (peer Commerzbank trading higher after results), VMW +1.7% (announced authorization of stock repurchase program of up to $1 bln of its Class A common stock), BKS +1.5% (Google and Barnes & Noble (BKS) want to compete with Amazon (AMZN) on speedy book delivery, according to reports), MNK +1.1% (announced settlement of OFIRMEV (acetaminophen) injection patent litigation with Fresenius Kabi USA), BAC +0.9% (reports suggesting $16.5 bln DoJ settlement).

Analyst comments: AOL +3.3% (upgraded to Buy from Hold at Cantor Fitzgerald), CCL +2.1% (upgraded to Buy from Neutral at BofA/Merrill), ANR +1.6% (upgraded to Neutral from Sell at UBS), ARMH +1.3% (upgraded to Buy from Hold at The Benchmark Company), WAG +1% (upgraded to Hold from Sell at Cantor Fitzgerald)

Gapping down
In reaction to disappointing earnings/guidance/SSS: THOR -26.4%, ELON -17%, BWC -12.6%, GEOS -9.5%, RNDY -9.5%, ANAD -9.1%, IO -8.4%, CSOD -8.2%, COUP -7.6%, TXTR -6.6%, OSUR -6%, TNGO -5.4%, ATML -5.2%, ATRS -5.2%, FTK -5.1%, ZEUS -4.9%, PHMD -4.7%, ERII -4.6%, CLDX -4.5%, ZU -4.5%, SD -4.5%, NVAX -4.1%, GPOR -3.9%, IXYS -3.9%, DVAX -3.9%, DRTX -3.7%, WIN -3.5%, CPA -3.3%, EVC -3.2%, NIHD -3.2%, BDBD -3%, CECE -3%, LAMR -3%, RDUS -2.8%, SABR -2.8%, IDCC -2.7%, FRED -2.6%, ACAS -2.4%, GMCR -2.2%, TSE -2.2%, SRPT -2%, MWE -1.9%, DSCI -1.9%, AUXL -1.8%, HIL -1.6%, MYL -1.6%, HRC -1.6%, YY -1.5%, CXW -1.5%, PRSC -1.5%, TOPS -1.5%, AGYS -1.4%, CPE -1.3%, LPI -1.3%, PHX -1.3%, CGI -1.1%, NVTL -1.1%, CTB -1%, MPEL -1%, COST -1%.

Select metals/mining stocks trading lower: TC -2.2%, AU -1.5%, AU -1.5%, HL -1.2%, HL -1.2%, IAG -1.1%, HMY -1%, BHP -0.5%, MT -0.4%.

Other news: NYMX -8% (Paul Averback sold in a private transaction for financial planning purposes 470,600 common shares of NYMX for a total consideration of $2.4 mln), UMPQ -3.5% (announces secondary offering of 15 mln shares held by Thomas H. Lee Partners and Warburg Pincus), SHPG -1.8% (still checking), PT -1.5% (still checking), YY -1.5% (Shanghai -1.3% overnight), EBS -1.3% (submits Biologics license application to FDA for Anthrax Immune Globulin Intravenous), ASTM -0.9% (filed for a $20 mln common stock offering), RSPP -0.8% (announces pricing of 10 mln shares of common stock offering at $25.65/share).

Analyst comments: NUS -0.6% (downgraded to Neutral from Overweight at JP Morgan), AET -0.6% (downgraded to Neutral from Buy at Goldman), UNH -0.6% (removed from Conviction Buy list at Goldman), PERI -0.5% (downgraded to Hold from Buy at Needham), VOD -0.4% (downgraded to Mkt Perform from Outperform at Raymond James).

Автор GT_support    Рубрики Торговые идеи

Чтобы первыми узнавать последние новости советуем вам подписаться на RSS. Если вы используете стандартные rss клиенты, можете кликнуть по ссылками ниже и читать новости в них, либо получать обновления на почту или твиттер:

Следуйте за мной на Twitter! Чат трейдеров в SKYPE!

Лучшие посты месяца

Свежие комментарии

Самое интересное

Партнеры

Облако тегов

Меню: